Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 10 Mar 2022 for Evolus, Inc., €58k. Read the official filing
Filing timeline
BuySaleCrystal Muilenburg
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Crystal Muilenburg: trading record in brief
Crystal Muilenburg, listed as senior executive, appears in our data through filings on Evolus, Inc. shares, published by SEC (Form 4). Between 10 August 2021 and 8 March 2022, the trades on record add up to 4 filings.
No open-market purchase appears, only 3 sales worth €160k. The rest of the record consists of 1 share grant. In 2022 alone, the filings show no purchases and 1 sale.
The record was last updated on 10 March 2022 with an open-market sale (€58k) in Evolus, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Crystal Muilenburg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
6,495 shares@ US$9.725453.2% of flowCommon StockSEC:0001570562-22-000086:0
50,000 shares0Common StockSEC:0001570562-22-000052:0
5,362 shares@ US$11.17940.012% mcap19.5% of flowCommon StockSEC:0001570562-21-000159:0
5,362 shares@ US$11.179446.8% of flowCommon StockSEC:0001570562-21-000154:0
4 of 4 declarations
